动脉粥样硬化血栓形成门诊患者心血管危险因素的国际患病率、认识和治疗

作     者：Bhatt D.L. Gabriel Steg P. Magnus Ohman E. 王鹏 

作者机构：Cleveland Clinic Foundation 9500 Euclid Ave Cleveland OH 44195 United States.Dr 

出 版 物：《世界核心医学期刊文摘(神经病学分册)》 (Digest of the World Core Medical Journals.Clinical Neurology)

年 卷 期：2006年第4期

页      面：2-3页

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：动脉粥样硬化血栓形成 患者 心血管危险因素 患病率 

摘      要：Context:Atherothrombosis is the leading cause of cardiovascular morbidity and mortality around the globe. To date, no single international database has characterized the atherosclerosis risk factor profile or treatment intensity of individuals with atherothrombosis. Objective: To determine whether atherosclerosis risk factor prevalence and treatment would demonstrate comparable patterns in many countries around the world. Design, Setting, and Participants: The Reduction of Atherothrombosis for Continued Health (REACH) Registry collected data on atherosclerosis risk factors and treatment. A total of 67 888 patients aged 45 years or older from 5473 physician practices in 44 countries had either established arterial disease (coronary artery disease [CAD], n = 40 258; cerebrovascular disease, n = 18843; peripheral arterial disease, n = 8273) or 3 or more risk factors for atherothrombosis (n = 12 389) between 2003 and 2004. Main Outcome Measures: Baseline prevalence of atherosclerosis risk factors, medication use, and degree of risk factor control. Results: Atherothrombotic patients throughout the world had similar risk factor profiles: a high proportion with hypertension (81.8% ), hypercholesterolemia (72.4% ), and diabetes (44.3% ). The prevalence of overweight (39.8% ), obesity (26.6% ), and morbid obesity (3.6% ) were similar in most geographic locales, but was highest in North America (overweight: 37.1% , obese: 36.5% , and morbidly obese: 5.8% ; P .001 vs other regions). Patients were generally undertreated with statins (69.4% overall; range: 56.4% for cerebrovascular disease to 76.2% for CAD), antiplatelet agents (78.6% overall; range: 53.9% for ≥ 3 risk factors to 85.6% for CAD), and other evidence-based risk reduction therapies. Current tobacco use in patients with established vascular disease was substantial (14.4% ). Undertreated hypertension (50.0% with elevated blood pressure at baseline), undiagnosed hyperglycemia (4.9% ), and impaired fasting glucose (36